
Semaglutide
5 mg · 10 mg
GLP-1 research reference with full identity package

Dual GIP/GLP-1 receptor agonist analogue
Tirzepatide is a dual GIP/GLP-1 receptor agonist analogue at the center of modern metabolic research programs. Available in 10 mg and 20 mg fills, verified at ≥ 99.1% purity with dual-receptor identity documentation.
84 vials of 10 mg in current lot · ships in 24 h cold-chain
| Format | Lyophilized powder · 3 mL amber vial |
|---|---|
| Net content | 10 mg |
| Available sizes | 10 mg · 20 mg |
| CAS | 2023788-19-2 |
| Molar mass | 4813.5 g/mol |
| Purity (HPLC) | ≥ 99.1% |
| Storage | Store at –20 °C. Cold-chain shipment included. |
Background reading on the analysis behind Tirzepatide’s certificate.
A technical comparison of Semaglutide vs. Tirzepatide in research models. Explore receptor kinetics, structural biochemistry, and laboratory reconstitution data.
BuyingWhy the same compound is sold in several vial sizes, what changes between them beyond the label, and how to pick the format that fits your work.

5 mg · 10 mg
GLP-1 research reference with full identity package
